Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Schlumberger NV — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Schlumberger NV trades at $48.75 (market cap $72.00B). The key difference: Schlumberger NV is far larger — about 2.3× GE HealthCare Technologies Inc. Common Stock's market cap, and Schlumberger NV pays the higher dividend (2.43%). Which is the better fit depends on your goals.
| GEHC | SLB | |
|---|---|---|
Market Cap | $30.93B | $72.00B |
Volume | 5,033,451 | 9,844,196 |
Sector | Health | Energy |
52-Week High | $88.16 | $60.10 |
52-Week Low | $59.48 | $32.57 |
Enterprise Value | $39.39B | $80.72B |
Dividend Yield | 0.23% | 2.43% |
Typical Hold Time | — | 99 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
SLB trades at $48.77, showing stable performance with no recent price movement. The stock demonstrates strong fundamental metrics including a 23.79 P/E ratio and 8.53% net income margin, supported by consistent earnings beats in recent quarters. Recent contract wins in Saudi Arabia, Oman, and Mozambique expand the company's international footprint and revenue visibility. Technical indicators show bearish momentum with the price near key support levels at $48.
SLB presents a compelling investment case with strong analyst support (84.85% buy rating) and a $64.58 consensus price target representing 32% upside potential. However, declining profit margins from 12.68% in 2023 to 8.52% projected for 2026 and bearish technical signals warrant caution. The company's expanding contract portfolio provides revenue stability, but investors should monitor margin pressures and oil market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
